The level of hypocretin 1 (Orexin A) in cerebrospinal fluid and the diagnosis of narcolepsy and other somnolent disorders

Internal Medicine

Volumn 42, Issue 8, 2003, Pages 634-635

  Kunimoto, Masanari ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Cerebrospinal fluid; Hypocretin 1; Narcolepsy; Orexin A

Indexed keywords

METHYLPREDNISOLONE; NEUROPEPTIDE; OREXIN A; OREXIN B;

CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; EDITORIAL; ENERGY BALANCE; GUILLAIN BARRE SYNDROME; HASHIMOTO DISEASE; HLA TYPING; HOMEOSTASIS; HUMAN; HYPERSOMNIA; LABORATORY DIAGNOSIS; MULTIPLE SCLEROSIS; NARCOLEPSY; POLYSOMNOGRAPHY; PROTEIN CEREBROSPINAL FLUID LEVEL; REM SLEEP; SLEEP DISORDER; SOMNOLENCE;

EID: 0042975138     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.634     Document Type: Editorial

References (14)

1. Aldrich MS. Narcolepsy. Neurology 42 (Suppl 6): 34-43, 1992.
2. Scammell TE. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 53: 154-166, 2003.
3. Mignot E. Genetic and familial aspects of narcolepsy. Neurolgy 50 (Suppl 1): S16-S22, 1998.
4. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585, 1998.
5. De Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Pro Natl Acad Sci USA 95: 322-327, 1998.
6. Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18: 9996-10015, 1998.
7. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355: 39-40, 2000.
8. Nishino S, Ripley B, Overeem S, et al. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 50: 381-388, 2001.
9. Ripley B, Overeem S, Fujiki N, et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57: 2253-2258, 2001.
10. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59: 1553-1562, 2002.
11. Ebrahim IO, Sharief MK, de Lacy S, et al. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia. J Neurol Neurosurg Psychiatry 74: 127-130, 2003.
12. Scammell TE, Nishino S, Mignot E, Saper CB. Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke. Neurology 56: 1751-1753, 2001.
13. Kato T, Kanbayashi T, Yamamoto K, et al. Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions. Intern Med 42: 743-745, 2003.
14. Samson WK, Gosnell B, Chang JK, Resch ZT, Murphy TC. Cardiovascular regulatory actions of the hypocretins in brain. Brain Res 831: 248-253, 1999.